To Read the full article visit http://www.beaconequityresearch.com/
As part of Skinvisible Inc.'s (OTCBB: SKVI) continued strategy to quickly expand its reach around the globe, the company recently announced that it has signed a marketing agreement with Avani International for India.
Terry Howlett, President and CEO of Skinvisible, Inc., has stated, "It is important for Skinvisible to develop partnerships with companies such as Avani as they have established relationships with pharmaceutical and consumer goods companies in India. This helps us fast track our marketing efforts in the country and generate license fees and royalties quicker than marketing in India ourselves."
About Skinvisible, Inc. (SKVI)
Skinvisible, Inc., through its wholly owned subsidiary Skinvisible Pharmaceuticals, Inc., develops innovative polymer delivery vehicles and related compositions which when topically applied hold active ingredients on the skin for up to four hours thereby affording the active agent an extended timeframe to perform its intended function. Aligned with its research and development focus, Skinvisible's primary objective is to license its patented technology and sell its trademarked polymer delivery vehicles to established brand manufacturers and marketers of prescription and over-the-counter ("OTC") products in the dermatological, medical, cosmetic, and skincare markets. The Company also produces a variety of products that incorporate its technology for private label clients, including antimicrobial hand sanitizers, sunless tanning sprays, sunscreens and skincare products.
